Scholars Central

Conference abstractPublished 2019

Effectiveness of Albendazole against viability of Entamoeba histolytica in experimental animals

Authors: Abdul Salam M Al-Mukhtar

University of Mosul, Iraq

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Aim: Intestinal amoebiasis is still an important health problem in developing countries of the world. One of the most issues for future biomedical research is the development of antimicrobial resistant, in order to search for alternative new anti-amoebic drugs. A study was carried out to evaluate the efficacy of Albendazole on the viability of Entamoeba histolytica clinical isolate from human which used for experimental animals. Method: All experimental animal models (30 albino mice and 30 rabbits) was divided into 3 groups, each group with either 10 mice or 10 rabbits, were orally infected with E. histolytica (clinical isolate), then after 7 days they were given drugs (Metronidazole or Albendazole) daily according to body weight prepared in advance for 5 days duration and in addition to the controls without drugs. Stool specimens of each group were examined microspically for viable trophozoites and the number of these trophozoites were counted with haemocytometer chamber, as compared to untreated and treated groups. Statistical methods used was student t-test. Result: The results showed infection of E. histolytica was able to be intiated in rabbits only. Albendazole and Metronidazole were highly effective (100%) on treatment of infected groups of rabbits. Torphozoites of E. histolytica was highly sensitive to Albendazole (25% viability) or to Metronidazole (22.7% viability) at a dose of 400 mg/kg/day and 250 mg/kg/day, respectively,which was significant in relation to the control 500% viability. However, the differences were significant at the level (p<0.01). Conclusion: The present study showed that the newly used Albendazole is very effective anti-ameobic drug as Metronidazole in rabbits.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Virology & Antiviral Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Virology & Antiviral Research
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Abdul Salam M Al-Mukhtar”